Unknown

Dataset Information

0

3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells.


ABSTRACT: Microtubule-targeted drugs are essential chemotherapeutic agents for various types of cancer. A series of 3-vinyl-?-lactams (2-azetidinones) were designed, synthesized and evaluated as potential tubulin polymerization inhibitors, and for their antiproliferative effects in breast cancer cells. These compounds showed potent activity in MCF-7 breast cancer cells with an IC50 value of 8 nM for compound 7s 4-[3-Hydroxy-4-methoxyphenyl]-1-(3,4,5-trimethoxyphenyl)-3-vinylazetidin-2-one) which was comparable to the activity of Combretastatin A-4. Compound 7s had minimal cytotoxicity against both non-tumorigenic HEK-293T cells and murine mammary epithelial cells. The compounds inhibited the polymerisation of tubulin in vitro with an 8.7-fold reduction in tubulin polymerization at 10 ?M for compound 7s and were shown to interact at the colchicine-binding site on tubulin, resulting in significant G2/M phase cell cycle arrest. Immunofluorescence staining of MCF-7 cells confirmed that ?-lactam 7s is targeting tubulin and resulted in mitotic catastrophe. A docking simulation indicated potential binding conformations for the 3-vinyl-?-lactam 7s in the colchicine domain of tubulin. These compounds are promising candidates for development as antiproiferative microtubule-disrupting agents.

SUBMITTER: Wang S 

PROVIDER: S-EPMC6630832 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells.

Wang Shu S   Malebari Azizah M AM   Greene Thomas F TF   O'Boyle Niamh M NM   Fayne Darren D   Nathwani Seema M SM   Twamley Brendan B   McCabe Thomas T   Keely Niall O NO   Zisterer Daniela M DM   Meegan Mary J MJ  

Pharmaceuticals (Basel, Switzerland) 20190411 2


Microtubule-targeted drugs are essential chemotherapeutic agents for various types of cancer. A series of 3-vinyl-β-lactams (2-azetidinones) were designed, synthesized and evaluated as potential tubulin polymerization inhibitors, and for their antiproliferative effects in breast cancer cells. These compounds showed potent activity in MCF-7 breast cancer cells with an IC<sub>50</sub> value of 8 nM for compound <b>7</b><b>s</b> 4-[3-Hydroxy-4-methoxyphenyl]-1-(3,4,5-trimethoxyphenyl)-3-vinylazetid  ...[more]

Similar Datasets

| S-EPMC10385824 | biostudies-literature
| S-EPMC4456358 | biostudies-literature
| S-EPMC10600176 | biostudies-literature
| S-EPMC5199013 | biostudies-literature
| S-EPMC3609251 | biostudies-literature
| S-EPMC5780039 | biostudies-literature
| S-EPMC5037722 | biostudies-literature
| S-EPMC5154514 | biostudies-literature
| S-ECPF-GEOD-12199 | biostudies-other
| S-EPMC6120250 | biostudies-literature